Abstract
The latency between acquisition of an initiating somatic driver mutation by a single-cell and clinical presentation with cancer is largely unknown. We describe a remarkable case of monozygotic twins presenting with CALR mutation-positive myeloproliferative neoplasms (MPNs) (aged 37 and 38 years), with a clinical phenotype of primary myelofibrosis. The CALR mutation was absent in T cells and dermal fibroblasts, confirming somatic acquisition. Whole-genome sequencing lineage tracing revealed a common clonal origin of the CALR-mutant MPN clone, which occurred in utero followed by twin-to-twin transplacental transmission and subsequent similar disease latency. Index sorting and single-colony genotyping revealed phenotypic hematopoietic stem cells (HSCs) as the likely MPN-propagating cell. Furthermore, neonatal blood spot analysis confirmed in utero origin of the JAK2V617F mutation in a patient presenting with polycythemia vera (aged 34 years). These findings provide a unique window into the prolonged evolutionary dynamics of MPNs and fitness advantage exerted by MPN-associated driver mutations in HSCs.
Original language | English |
---|---|
Pages (from-to) | 1207-1211 |
Number of pages | 5 |
Journal | Nature Medicine |
Volume | 28 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Jun 2022 |
Keywords
- Calreticulin
- Humans
- Janus Kinase 2/genetics
- Mutation/genetics
- Myeloproliferative Disorders/genetics
- Primary Myelofibrosis/genetics
- Twins, Monozygotic/genetics